Research and Development

Showing 15 posts of 9599 posts found.

Asia Pacific vaccines market requires flexible, targeted portfolios

July 2, 2009 Research and Development, Sales and Marketing Asia, vaccines

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …

Onglyza and Cimzia recommended by CHMP

July 2, 2009 Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza

Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …

Pfizer halts Sutent colon cancer trial

July 2, 2009 Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …

Roche quits ABPI

June 30, 2009 Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

Is the law good for your health?

June 30, 2009 Research and Development Les Rose, law, science

 A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …

Bayer signs deal with Celera on cancer targets

June 30, 2009 Research and Development, Sales and Marketing Bayer, Celera

Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …

PPD backs away from new facility lease

June 30, 2009 Research and Development CRO, PPD

PPD has cancelled plans to occupy a facility at the North Carolina Research Campus in the US, blaming construction delays …

Contract research sector: news in brief

June 29, 2009 Research and Development CRO, chiltern

Pharmafocus presents a round-up of developments in the contract research sector, including a successful IPO by Medidata, Pierrel's imminent acquisition …

Novartis gains approval for first Japanese biosimilar

June 25, 2009 Research and Development, Sales and Marketing Novartis, generics

Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …

Merck takes aim at neglected tropical diseases

June 25, 2009 Research and Development, Sales and Marketing Africa, Merck, Orphan

Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …

GSK signs arthritis drug development collaboration

June 25, 2009 Research and Development, Sales and Marketing Deals, GSK

GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …

Astellas signs European deal in pain management

June 23, 2009 Research and Development, Sales and Marketing Astellas

Astellas has struck a deal with Californian company NeurogesX to market in Europe a treatment for pain linked to peripheral …
The Gateway to Local Adoption Series

Latest content